• YOUTH
    Current Issues Lifestyle Hobi Interest Tech
  • SPORT
    Mainbasket Esports DBL PLAY Mainlari
  • ENTERTAINMENT
  • YOUTHCON
Log In / Sign Up
Youth
Current Issues Lifestyle Hobi Interest Tech
Sport
Mainbasket Esports DBL PLAY Mainlari
Entertainment
Search

The Latest with 'molnupiravir' Tag

Current Issues

Ada 4 Obat untuk Terapi Covid-19 yang Sudah Dapat EUA Dari BPOM

Dwiwa

Posted on June 30th 2022

Posted By Dwiwa
Current Issues

Molnupiravir Dapat Izin BPOM, Bagaimana Efektivitasnya Melawan Omicron?

Dwiwa

Posted on January 11th 2022

Posted By Dwiwa
Current Issues

Pil Covid-19 Pfizer Dapat Izin Penggunaan Darurat di AS, Bisa Digunakan di Rumah

Dwiwa

Posted on December 23rd 2021

Posted By Dwiwa
Current Issues

Pfizer Sebut Pil Covid-19 Hampir 90 Persen Lindungi dari Rawat Inap dan Kematian

Dwiwa

Posted on December 15th 2021

Posted By Dwiwa
Current Issues

Pil Covid-19 Molnupiravir Bakal Datang Desember, Menkes: Harga di Bawah Sejuta

Dwiwa

Posted on November 8th 2021

Posted By Dwiwa
Current Issues

Pil Covid Pfizer Diklaim Kurangi Risiko Rawat Inap dan Kematian Hampir 90 Persen

Dwiwa

Posted on November 6th 2021

Posted By Dwiwa
Current Issues

Menkes Upayakan Obat Covid-19 Molnupiravir Tiba Akhir Tahun

Dwiwa

Posted on October 26th 2021

Posted By Dwiwa
  • «
  • 1 (current)
  • 2
  • »

Pilihan Editor

Gak Bisa Selfie Tanpa Pakai Filter? Ini Dampaknya ke Kesehatan Mental

Fullball Olahraga Baru Ciptaan Anak Indonesia

Mengenal 11 Seni Bela Diri dalam Film ‘John Wick’, Ada yang dari Indonesia lho!

Mainmain.id adalah

Portal berita online anak muda yang menyajikan berita terupdate seputar youth, sports, dan entertainment. Mainmain.id juga sebagai platform kolaborasi untuk para penulis muda.

Kontak Kami!

DBL Indonesia Office - Surabaya Town Square - Mezzanine Level, Jl Hayam Wuruk No 6, Surabaya
redaksi@mainmain.id

Jaringan Media

DISWAY
DBL ID
MainBasket
MainSepeda
MainLari

Media Lainnya

Copyright © 2018 MAINMAIN.ID. All Rights Reserved. Any commercial use or distribution without the express written consent of Mainmain is strictly prohibited.
Redaksi | Tentang Kami | Pedoman Media Siber dan Kode Perilaku | Privacy Policy | Penawaran Bisnis

Forgot your password?

or
Login with Facebook
Login with Google

not a member?
Register

Hi, can we know more about you ?

Tell us about your school

Create your login information